The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...
As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback